MXPA04004304A - Composicion farmaceutica que comprende polipeptidos del factor vii y polipeptidos del factor v. - Google Patents

Composicion farmaceutica que comprende polipeptidos del factor vii y polipeptidos del factor v.

Info

Publication number
MXPA04004304A
MXPA04004304A MXPA04004304A MXPA04004304A MXPA04004304A MX PA04004304 A MXPA04004304 A MX PA04004304A MX PA04004304 A MXPA04004304 A MX PA04004304A MX PA04004304 A MXPA04004304 A MX PA04004304A MX PA04004304 A MXPA04004304 A MX PA04004304A
Authority
MX
Mexico
Prior art keywords
factor
polypeptides
pharmaceutical composition
factor vii
vii
Prior art date
Application number
MXPA04004304A
Other languages
English (en)
Spanish (es)
Inventor
Rojkjaer Rasmus
Original Assignee
Novo Nordisk Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk Healthcare Ag filed Critical Novo Nordisk Healthcare Ag
Publication of MXPA04004304A publication Critical patent/MXPA04004304A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MXPA04004304A 2001-11-09 2002-11-05 Composicion farmaceutica que comprende polipeptidos del factor vii y polipeptidos del factor v. MXPA04004304A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101660 2001-11-09
PCT/DK2002/000736 WO2003039584A1 (en) 2001-11-09 2002-11-05 Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides

Publications (1)

Publication Number Publication Date
MXPA04004304A true MXPA04004304A (es) 2004-08-11

Family

ID=8160820

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04004304A MXPA04004304A (es) 2001-11-09 2002-11-05 Composicion farmaceutica que comprende polipeptidos del factor vii y polipeptidos del factor v.

Country Status (16)

Country Link
EP (1) EP1446149A1 (xx)
JP (1) JP2005511599A (xx)
KR (1) KR20050043734A (xx)
CN (1) CN1596125A (xx)
AU (1) AU2002340779B2 (xx)
BR (1) BR0213953A (xx)
CA (1) CA2464615A1 (xx)
CZ (1) CZ2004543A3 (xx)
HU (1) HUP0401985A3 (xx)
IL (1) IL161544A0 (xx)
MX (1) MXPA04004304A (xx)
NO (1) NO20042380L (xx)
PL (1) PL370634A1 (xx)
RU (1) RU2004117534A (xx)
WO (1) WO2003039584A1 (xx)
ZA (1) ZA200403271B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0302052A3 (en) 1999-07-14 2005-12-28 Novo Nordisk Healthcare Ag Use of fviia or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis
EP2392655A3 (en) 2003-09-09 2012-02-29 Novo Nordisk Health Care AG Coagulation factor VII polypeptides
JP2007520530A (ja) * 2004-02-05 2007-07-26 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト 外傷の遅発型合併症の治療のための、ＶＩＩａ因子又はＶＩＩａ因子等価物の使用
FR2894831B1 (fr) * 2005-12-16 2008-02-15 Lab Francais Du Fractionnement Colle biologique exempte de thrombine et son utilisation comme medicament.
EP2004214B1 (en) * 2006-03-16 2012-11-07 STELLARIS PHARMACEUTICALS Aps Local treatment with factor vii
US10407488B2 (en) * 2013-11-04 2019-09-10 The Regents Of The University Of California Therapy for treatment or prevention of conditions associated with bleeding or hypocoagulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3810080B2 (ja) * 1994-04-22 2006-08-16 ステイヒテイング・セントラール・ラボラトリウム・バン・デ・ブレドトランスフシーデイーンスト・バン・ヘト・ネーデルランドセ・ロデ・クルイス 血液凝固カスケードにおける疾患を検出および治療するための方法および手段
AU7907398A (en) * 1997-06-23 1999-01-04 Novo Nordisk A/S Use of fviia for the treatment of bleedings in patients with a normal blood clotting cascade and normal platelet function
EP1076698A2 (en) * 1998-05-14 2001-02-21 Battelle Memorial Institute Transgenic plant-derived human blood coagulation factors

Also Published As

Publication number Publication date
EP1446149A1 (en) 2004-08-18
JP2005511599A (ja) 2005-04-28
NO20042380L (no) 2004-06-08
BR0213953A (pt) 2004-08-31
IL161544A0 (en) 2004-09-27
WO2003039584A1 (en) 2003-05-15
PL370634A1 (en) 2005-05-30
RU2004117534A (ru) 2005-05-10
AU2002340779B2 (en) 2007-08-02
CZ2004543A3 (cs) 2004-08-18
HUP0401985A3 (en) 2009-03-30
ZA200403271B (en) 2004-11-08
KR20050043734A (ko) 2005-05-11
HUP0401985A2 (hu) 2004-12-28
CN1596125A (zh) 2005-03-16
CA2464615A1 (en) 2003-05-15

Similar Documents

Publication Publication Date Title
YU68002A (sh) Modifikovani faktor viii
HK1145692A1 (zh) 人血管生成素- 的特異結合劑
DE60225118D1 (de) Kombinierte verwendung von faktor vii polypeptiden und faktor viii polypeptiden
EP2949658A3 (en) Peptides that specifically bind HGF receptor (cMet) and uses thereof
IL160289A0 (en) Modified transferrin fusion proteins
PT1346034E (pt) Polipéptido da protease de clivagem do factor de von willebrand (vwf), ácido nucleico que codifica o polipéptido e utilização do polipéptido
DE60120712D1 (en) Kallikrein gen
WO2003007689A3 (en) Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids
PL374080A1 (en) Processes for the preparation of fibrinogen
MXPA03010684A (es) Peptidos y el uso de los mismos para oscurecer la piel.
WO2005035570A3 (en) Variants of cd40l protein
MXPA04004304A (es) Composicion farmaceutica que comprende polipeptidos del factor vii y polipeptidos del factor v.
AU8184301A (en) Inhibitors for the blood-clotting factor xa
HUP0400976A2 (hu) VII-es faktor polipeptideket és XI-es faktor polipeptideket tartalmazó gyógyszerészeti összetételek
MXPA04002103A (es) Una proteina de union a caspasa-8, su preparacion y uso.
MXPA04004303A (es) Composicion farmaceutica que comprende polipeptidos del factor vii y polipeptidos pai-1.
MX9504686A (es) Proteinas con propiedades fibrinoliticas y reductoras de la coagulacion.
WO2002078641A3 (en) Pyrrolidine sulfonamides
EP1458736A4 (en) RECOMBINANT RINDER THROMBIN
MXPA04001526A (es) Composiciones de polipetidos kgf.
WO2002059153A3 (en) Anticoagulants and their uses
WO2002012283A3 (en) Disintegrin homologs, zsnk10, zsnk11, and zsnk12
PT1485483E (pt) Vegf activo resistente à proteólise
WO2002000833A3 (en) A novel polypeptide, a proline rich gamma-carboxyglutamic acid protein 113.31 and the polynucleotide encoding the polypeptide
WO2002068458A3 (en) Disintegrin homolog, zsnk16

Legal Events

Date Code Title Description
FG Grant or registration